Cencora, Inc. (COR) stock

CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3022% above fair value

$349.38−0.50 (-0.14%)

Close on Nov 12, 2026Market cap $66.67BP/E 25.9Yield 0.63%

Cencora price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cencora's price to sales ratio was 0.2× on Nov 11, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.1× to 0.2×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	0.2×	−0.0
2025	Dec 31, 2025	0.2×	+0.1
2024	Dec 31, 2024	0.1×	−0.0
2023	Dec 29, 2023	0.2×	+0.0
2022	Dec 30, 2022	0.1×	+0.0
2021	Dec 31, 2021	0.1×	+0.0
2020	Dec 31, 2020	0.1×	+0.0
2019	Dec 31, 2019	0.1×	+0.0
2018	Dec 31, 2018	0.1×	−0.0
2017	Dec 29, 2017	0.1×	+0.0
2016	Dec 30, 2016	0.1×	−0.0
2015	Dec 31, 2015	0.2×	−0.0
2014	Dec 31, 2014	0.2×	−0.0
2013	Dec 31, 2013	0.2×	+0.1
2012	Dec 31, 2012	0.1×	+0.0
2011	Dec 30, 2011	0.1×	+0.0
2010	Dec 31, 2010	0.1×	+0.0
2009	Dec 31, 2009	0.1×	–